Ma, Qian
Wang, Weiwei
Funding for this research was provided by:
Xi'an Science and Technology Project (21YXYJ0044)
Shaanxi Science and Technology Project (2022SF-434)
Article History
Received: 6 May 2024
Accepted: 4 December 2024
First Online: 18 December 2024
Declarations
:
: Ethical approval was not applicable. This study had no novel intervention and all treatments were standard treatments of an oculocutaneous albinism combined with angle closure. All patients gave written, informed consent to publish these cases and any accompanying images.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: The authors declare that they have no competing interests.